Inventor · disambiguated record
Pin Wang
Also filed as: WANG PIN · WANG PIN-YI
18 granted patents·14 pending applications·285 citations·filing 2003–2023
95Inventor score
Files withCALIFORNIA INST OF TECHN10UNIV SOUTHERN CALIFORNIA6WANG PIN4RES INST NATIONWIDE CHILDRENS HOSPITAL2YANG LILI2
Top patents by PatentIndex Score
32 records- 0196US8119772B2MART-1 T cell receptorsYANG LILI·Filed 2007·Granted Feb 21, 2012·136 cites·14 claims
- 0292US9994867B2Method of targeting gene delivery using viral vectorsCALIFORNIA INST OF TECHN·Filed 2014·Granted Jun 12, 2018·9 cites·9 claims
- 0392US8821856B2Method of targeted gene delivery using viral vectorsBALTIMORE DAVID·Filed 2011·Granted Sep 2, 2014·12 cites·12 claims
- 0492US8329162B2Targeted gene delivery for dendritic cell vaccinationWANG PIN·Filed 2007·Granted Dec 11, 2012·14 cites·17 claims
- 0592US7139665B2Computational method for designing enzymes for incorporation of non natural amino acids into proteinsCALIFORNIA INST OF TECHN·Filed 2003·Granted Nov 21, 2006·34 cites·30 claims
- 0691US9840721B2Recombinant retrovirus pseudotyped with E2 alphavirus glycoproteinCALIFORNIA INST OF TECHN·Filed 2016·Granted Dec 12, 2017·6 cites·7 claims
- 0791US9303072B2Method of stimulating an immune response using a pseudotyped lentivirusCALIFORNIA INST OF TECHN·Filed 2014·Granted Apr 5, 2016·9 cites·23 claims
- 0890US8273345B2Targeted gene delivery to dendritic cellsWANG PIN·Filed 2011·Granted Sep 25, 2012·10 cites·8 claims
- 0989US8518666B2Site-specific incorporation of amino acids into moleculesWANG PIN·Filed 2007·Granted Aug 27, 2013·17 cites·34 claims
- 1089US8372390B2Recombiant lentivirus comprising an E2 alphavirus glycoprotein that binds to DC-SIGNCALIFORNIA INST OF TECHN·Filed 2010·Granted Feb 12, 2013·8 cites·7 claims
- 1188US8906359B2Recombinant retrovirus pseudotyped with a E2 alphavirus glycoproteinCALIFORNIA INST OF TECHN·Filed 2013·Granted Dec 9, 2014·6 cites·20 claims
- 1287US8715640B2Packaging cells for producing retrovirus pseudotyped with an E2 alphavirus glycoproteinWANG PIN·Filed 2010·Granted May 6, 2014·7 cites·8 claims
- 1385US8980581B2Site-specific incorporation of amino acids into moleculesCALIFORNIA INST OF TECHN·Filed 2013·Granted Mar 17, 2015·5 cites·23 claims
- 1484US10822419B2Masking chimeric antigen receptor T cells for tumor-specific activationUNIV SOUTHERN CALIFORNIA·Filed 2016·Granted Nov 3, 2020·5 cites·20 claims
- 1584US10266847B2Methods of delivering a pseudotyped lentivirusCALIFORNIA INST OF TECHN·Filed 2017·Granted Apr 23, 2019·2 cites·9 claims
- 1681US8552150B2MART-1 T cell receptorsYANG LILI·Filed 2012·Granted Oct 8, 2013·5 cites·20 claims
- 1776US10696984B2Packaging cell for making a pseudotyped lentivirusCALIFORNIA INST OF TECHN·Filed 2019·Granted Jun 30, 2020·0 cites·8 claims
- 1861US2021369776A1Combinational tcr-t cell therapy targeting tumor antigens, tgf-beta, and immune checkpointsGUANGDONG TCRCURE BIOPHARMA TECH CO LTD·Filed 2019·Application pending·0 cites
- 1960US2006177865A1Computational method for designing enzymes for incorporation of amino acid analogs into proteinsCALIFORNIA INST OF TECHN·Filed 2006·Application pending·0 cites
- 2059US2025353907A1Cd19-targeting chimeric antigen receptor and use thereofSHANGHAI SIMNOVA BIOTECHNOLOGY CO LTD·Filed 2023·Application pending·0 cites
- 2154US2023310601A1Chimeric antigen receptor-modified immune cells expressing a secretable bispecific trap protein and uses thereofUNIV SOUTHERN CALIFORNIA·Filed 2023·Application pending·0 cites
- 2252US2023310702A1Self-assembling peptides, preparation methods, self-assembling peptide formulations and useSUCCESS BIO TECH CO LTD·Filed 2021·Application pending·0 cites
- 2352US2022257655A1Engineered off-the-shelf immune cells and methods of use thereofUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 2446US2022257760A1Cancer-targeted, virus-encoded, regulatable t (catvert) or nk cell (catvern) linkersRES INST NATIONWIDE CHILDRENS HOSPITAL·Filed 2020·Application pending·0 cites
- 2545US2021095029A1Compositions and methods for treating cancerUNIV SOUTHERN CALIFORNIA·Filed 2018·Application pending·0 cites
- 2644US2014356414A1Targeted Crosslinked Multilamellar LiposomesUNIV SOUTHERN CALIFORNIA·Filed 2014·Application pending·0 cites
- 2742US12480097B2Syncytial oncolytic herpes simplex mutants as potent cancer therapeuticsRES INST NATIONWIDE CHILDRENS HOSPITAL·Filed 2020·Granted Nov 25, 2025·0 cites·16 claims
- 2838US2020197533A1Combination cancer therapy using chimeric antigen receptor engineered natural killer cells as chemotherapeutic drug carriersUNIV SOUTHERN CALIFORNIA·Filed 2018·Application pending·0 cites
- 2937US2019358343A1Adoptive transfer of car t cells with surface-conjugated drug-loaded nanoparticles and uses thereofUNIV SOUTHERN CALIFORNIA·Filed 2018·Application pending·0 cites
- 3037US2018291458A1Use of gastric cancer gene panelNANJING KDRB BIOTECHNOLOGY INC LTD·Filed 2016·Application pending·0 cites
- 3136US2020046769A1Dual function engineered t cells with hpv e6 specificity and pd-1 blockadeTCRCURE BIOPHARMA CORP·Filed 2019·Application pending·0 cites
- 3234US2019112729A1Novel set of biomarkers useful for predicting lung cancer survivalHANG BO·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Pin Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →